Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1291PDF: 612HTML: 269 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3823PDF: 958HTML: 6883 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1788PDF: 656HTML: 297 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
5147PDF: 1366HTML: 1938Untitled: 226Untitled: 210 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2522PDF: 1495HTML: 2025 -
EFFECTS OF FACTOR XIII DEFICIENCY ON THROMBOELASTOGRAPHY. THROMBELASTOGRAPHY WITH CALCIUM AND LYSIS BY ADDITION OF STREPTOKINASE IS MORE SENSITIVE THAN SOLUBILITY TESTS
3211PDF: 1035HTML: 1959Untitled: 206Untitled: 224Untitled: 207Untitled: 224Untitled: 210 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3399PDF: 957HTML: 1553Fig.1 CHL-R paper: 257Fig 2 CHL-R paper: 282 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4541PDF: 1818HTML: 1127 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4416PDF: 2008HTML: 5521Table 1: 255 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3021PDF: 1071HTML: 5654 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1616HTML: 683PDF: 903 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
2261PDF: 897HTML: 380 -
Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients CALR mutation survey by HRM in ET patients
1379PDF: 793HTML: 555 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1500PDF: 874HTML: 3144 -
Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature
90PDF: 111Suppl. Files: 17Html: 41Html Suppl. Files: 22 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2418PDF: 1059HTML: 7701Untitled: 320Fig2: 221Fig3: 214Fig4: 227 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
1081PDF: 1292HTML: 135 -
BETA-GLOBIN GENE MUTATIONS IN TURKISH CHILDREN WITH BETA-THALASSEMIA: RESULTS FROM A SINGLE CENTER STUDY
1819PDF: 742HTML: 1678Beta-globin Gene Mutations in Turkish Children with Beta-Thalassemia: Results from a Single Center Study: 226 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1385PDF: 1132HTML: 265 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3216PDF: 942HTML: 7312Kost Fig1: 225Kost Fig 2: 212Kost Fig3: 224Kost Fig 4: 238Kost Fig5: 233Kost fig 6: 215 -
-
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4910PDF: 1619HTML: 2271Untitled: 269Untitled: 284Untitled: 304Untitled: 248Untitled: 271 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4630PDF: 3814HTML: 377 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1724PDF: 612HTML: 911 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4509Suppl. Files: 1236PDF: 1147Html: 301 -
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1968PDF: 855HTML: 246 -
GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS
1997PDF: 1352HTML: 11582Figure1: 205Figure 2: 221 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1728PDF: 1970Suppl. Files: 255HTML: 113 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1867PDF: 927HTML: 464Fig1: 276Fig.2: 296Fig. 3: 231Fig. 5: 241Fig. 4: 268 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1495PDF: 861HTML: 1035 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2655PDF: 1240HTML: 167







